Katrin Bürk

Katrin Bürk publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Katrin Bürk sits on this spectrum.

Katrin Bürk D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Katrin Bürk sits on this spectrum.

Best Publications

• Spectrin mutations cause spinocerebellar ataxia type 5

  Yoshio Ikeda;Katherine A Dick;Marcy R Weatherspoon;Dan Gincel

  439
  Citations

• Diagnosis and treatment of Friedreich ataxia: a European perspective

  Jörg B. Schulz;Sylvia Boesch;Katrin Bürk;Alexandra Dürr

  347
  Citations

• Autosomal dominant cerebellar ataxia type I Clinical features and MRI in families with SCA1, SCA2 and SCA3

  K. Bürk;M. Abele;M. Fetter;J. Dichgans

  345
  Citations

• Oxidative stress in patients with Friedreich ataxia

  J.B. Schulz;T. Dehmer;L. Schöls;H. Mende

  336
  Citations

• The aetiology of sporadic adult‐onset ataxia

  M. Abele;K. Bürk;L. Schöls;S. Schwartz

  296
  Citations

• Molecular and Clinical Correlations in Spinocerebellar Ataxia 2: A Study of 32 Families

  Géraldine Cancel;Alexandra Dürr;Olivier Didierjean;Georges Imbert

  284
  Citations

• Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3

  K Bürk;Christoph Globas;S Bösch;Thomas Klockgether

  281
  Citations

• Sporadic cerebellar ataxia associated with gluten sensitivity.

  K Bürk;S Bösch;C A Müller;A Melms

  244
  Citations

• Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3.

  Bürk K;Fetter M;Abele M;Laccone F

  233
  Citations

• Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data

  Kathrin Reetz;Imis Dogan;Imis Dogan;Ana S Costa;Manuel Dafotakis

  232
  Citations

• Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data

  Heike Jacobi;Kathrin Reetz;Kathrin Reetz;Sophie Tezenas du Montcel;Peter Bauer

  205
  Citations

• Comparison of three clinical rating scales in Friedreich ataxia (FRDA).

  Katrin Bürk;Katrin Bürk;Ulrike Mälzig;Stefanie Wolf;Suzette Heck

  194
  Citations

• Cognitive deficits in spinocerebellar ataxia 2.

  K. Bürk;C. Globas;S. Bösch;S. Gräber

  185
  Citations

• The humoral response in the pathogenesis of gluten ataxia

  Unknown

  170
  Citations

• Friedreich Ataxia: current status and future prospects

  Katrin Bürk

  164
  Citations

• Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study

  Kathrin Reetz;Imis Dogan;Ralf-Dieter Hilgers;Paola Giunti

  150
  Citations

• Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.

  Ullrich Wüllner;Michael Reimold;Michael Abele;Katrin Bürk

  129
  Citations

• Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).

  W. Scherzed;E. R. Brunt;H. Heinsen;R. A. de Vos

  129
  Citations

• SCA2 trinucleotide expansion in German SCA patients.

  Olaf Riess;Franco A. Laccone;Suzana Gispert;Ludger Schöls

  124
  Citations

• Cerebellar ataxia with glutamic acid decarboxylase autoantibodies

  M. Abele;M. Weller;S. Mescheriakov;K. Bürk

  123
  Citations